Muye Xia
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Optimizing healthcare resources in pyogenic liver abscess: a dual-threshold HDL-CRP model for predicting hospitalization duration across multi-cohorts.
Journal: Frontiers in medicine
Published: September 29, 2025
Longitudinal analysis of metabolic changes in people with HIV on integrase inhibitor-based versus efavirenz-based therapy: a prospective real-world cohort study in China.
Journal: BMC infectious diseases
Published: September 24, 2025
Soluble Programmed Cell Death-1: A Potential Predictor of HBsAg Loss in Pediatric Patients with Chronic Hepatitis B Undergoing Peginterferon Therapy.
Journal: ImmunoTargets and therapy
Published: June 03, 2025
Baseline HBsAg quantitative and CD4 T cell counts are associated with HBsAg loss in people living with HIV/HBV coinfection after combined antiretroviral therapy.
Journal: Frontiers in cellular and infection microbiology
Published: February 04, 2024
Expression and prognostic significance of the PD-1/PD-L1 pathway in AIDS-related non-Hodgkin lymphoma.
Journal: Cancer medicine
Published: January 10, 2024
DNA mismatch repair in HIV-Associated Lymphoma: Lost in Translation?
Journal: The Journal of infection
Published: December 26, 2023
Bcl-2 Antagonist Obatoclax Reactivates Latent HIV-1 via the NF-κB Pathway and Induces Latent Reservoir Cell Apoptosis in Latently Infected Cells.
Journal: ACS infectious diseases
Published: October 05, 2023
Prospective observational study of baloxavir marboxil in adults and adolescents with uncomplicated influenza from China.
Journal: Frontiers in microbiology
Published: September 13, 2023
Effective Analysis of Antiviral Treatment in Patients with HBeAg-Seropositive Chronic Hepatitis B with ALT < 2 Upper Limits of Normal: A Multi-center Retrospective Cohort Study.
Journal: Infectious diseases and therapy
Published: September 18, 2022
Soluble Programmed Cell Death-1 is a Novel Predictor of HBsAg Loss in Chronic Hepatitis B Patients When Long-Term Nucleos(t)ide Analog Treatment is Discontinued.
Journal: Infection and drug resistance
Published: February 05, 2022
aMAP Score as a Predictor for Long-Term Outcomes in Patients with HBV-Related Acute-on-Chronic Liver Failure.
Journal: International journal of general medicine
Published: October 09, 2021
Last Updated: 09/26/2026